Risk factors

Abeona Therapeutics (ABEO) risk factors

Item 1A of every Abeona Therapeutics Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open ABEO in Gloom →
Abeona Therapeutics' chart, financials and news, free in your browser.Open ABEO in Gloom →
  • FY2025 10-K risk factors
    55 risks17 new6 dropped11 reworded

    ZEVASKYN commercialization now dominates risk disclosure, including market acceptance, treatment-center coordination, manufacturing, supply, regulation, and reimbursement.

    Filed Mar 17, 2026
  • FY2024 10-K risk factors
    44 risks

    Abeona Therapeutics faces clinical trial, regulatory, and commercialization uncertainties, dominated by risks around securing approval and funding for its lead product pz-cel.

    Filed Mar 20, 2025